Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2411)
All Articles published online
|
Oct 15, 1998 (publication date) through Jun 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang WL, Gu GY, Hu M. Expression and significance of HBV genes and their antigens in human primary intrahepatic cholangiocarcinoma. World J Gastroenterol 1998; 4(5): 392-396 [PMID: 11819329 DOI: 10.3748/wjg.v4.i5.392] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v4/i5/392.htm |
| Number | Citing Articles |
| 1 |
Yizhou Wang, Ye Yuan, Dongqing Gu. Hepatitis B and C virus infections and the risk of biliary tract cancers: a meta-analysis of observational studies. Infectious Agents and Cancer 2022; 17(1) doi: 10.1186/s13027-022-00457-9
|
| 2 |
D. Nart, Y. Ertan, E.E. Pala, M. Zeytunlu, M. Kilic, F. Yilmaz. Intrahepatic Cholangiocarcinoma Arising in Chronic Viral Hepatitis–Associated Cirrhosis: Two Transplant Cases. Transplantation Proceedings 2008; 40(10): 3813 doi: 10.1016/j.transproceed.2008.06.071
|
| 3 |
Yu Zhou, Quanbo Zhou, Qing Lin, Ruiwan Chen, Yuanfeng Gong, Yimin Liu, Min Yu, Bing Zeng, Kaiwen Li, Rufu Chen, Zhihua Li. Evaluation of risk factors for extrahepatic cholangiocarcinoma: ABO blood group, hepatitis B virus and their synergism. International Journal of Cancer 2013; 133(8): 1867 doi: 10.1002/ijc.28196
|
| 4 |
Zhizhen Li, Qingxiang Gao, Yingjun Wu, Xiaoming Ma, Fangyan Wu, Siyu Luan, Sunrui Chen, Siyuan Shao, Yang Shen, Ding Zhang, Feiling Feng, Lei Yuan, Shaohua Wei. HBV infection effects prognosis and activates the immune response in intrahepatic cholangiocarcinoma. Hepatology Communications 2024; 8(1) doi: 10.1097/HC9.0000000000000360
|
| 5 |
Masakazu Yamamoto, Shunichi Ariizumi, Takehito Otsubo, Hideo Katsuragawa, Satoshi Katagiri, Masayuki Nakano, Ken Takasaki. Intrahepatic cholangiocarcinoma diagnosed preoperatively as hepatocellular carcinoma. Journal of Surgical Oncology 2004; 87(2): 80 doi: 10.1002/jso.20091
|
| 6 |
Vivekanandan Perumal, Jianzhou Wang, Paul Thuluvath, Michael Choti, Michael Torbenson. Hepatitis C and hepatitis B nucleic acids are present in intrahepatic cholangiocarcinomas from the United States. Human Pathology 2006; 37(9): 1211 doi: 10.1016/j.humpath.2006.04.012
|
| 7 |
Yiqi Wu, Tianzhen Wang, Shengqian Ye, Ran Zhao, Xiaohui Bai, Yingying Wu, Kenji Abe, Xiaoming Jin. Detection of hepatitis B virus DNA in paraffin-embedded intrahepatic and extrahepatic cholangiocarcinoma tissue in the northern Chinese population. Human Pathology 2012; 43(1): 56 doi: 10.1016/j.humpath.2011.04.004
|
| 8 |
M. Tanaka, H. Tanaka, H. Tsukuma, A. Ioka, A. Oshima, T. Nakahara. Risk factors for intrahepatic cholangiocarcinoma: a possible role of hepatitis B virus. Journal of Viral Hepatitis 2010; 17(10): 742 doi: 10.1111/j.1365-2893.2009.01243.x
|
| 9 |
Ning-fu Peng, Le-qun Li, Xiao Qin, Ya Guo, Tao Peng, Kai-yin Xiao, Xi-gang Chen, Yu-feng Yang, Zhi-xiong Su, Bin Chen, Ming Su, Lu-nan Qi. Evaluation of Risk Factors and Clinicopathologic Features for Intrahepatic Cholangiocarcinoma in Southern China: A Possible Role of Hepatitis B Virus. Annals of Surgical Oncology 2011; 18(5): 1258 doi: 10.1245/s10434-010-1458-5
|
| 10 |
Sheng-Quan Zou, Zhen-Liang Qu, Zhan-Fei Li, Xin Wang. Hepatitis B virus X gene induces human telomerase reverse transcriptase mRNA expression in cultured normal human cholangiocytes. World Journal of Gastroenterology 2004; 10(15): 2259-2262 doi: 10.3748/wjg.v10.i15.2259
|
| 11 |
Teng-Yu Lee, Yao-Chun Hsu, Shi-Hang Yu, Jaw-Town Lin, Ming-Shiang Wu, Chun-Ying Wu. Effect of Nucleos(t)ide Analogue Therapy on Risk of Intrahepatic Cholangiocarcinoma in Patients With Chronic Hepatitis B. Clinical Gastroenterology and Hepatology 2018; 16(6): 947 doi: 10.1016/j.cgh.2017.09.031
|
| 12 |
Wangta Liu, Jim-Ray Chen, Chih-Hao Hsu, Yen-Hsing Li, Yi-Meng Chen, Chien-Yuan Lin, Shin-Jie Huang, Zen-Kuei Chang, Yen-Chun Chen, Chi-Hsueh Lin, Hong-Yi Gong, Ching-Chun Lin, Koichi Kawakami, Jen-Leih Wu. A zebrafish model of intrahepatic cholangiocarcinoma by dual expression of hepatitis B virus X and hepatitis C virus core protein in liver. Hepatology 2012; 56(6): 2268 doi: 10.1002/hep.25914
|
| 13 |
Ruben R. Plentz, Nisar P. Malek. Clinical presentation, risk factors and staging systems of cholangiocarcinoma. Best Practice & Research Clinical Gastroenterology 2015; 29(2): 245 doi: 10.1016/j.bpg.2015.02.001
|
| 14 |
Mengge Li, Min Du, Hui Cong, Yuanyuan Gu, Yuan Fang, Jin Li, Yu Gan, Hong Tu, Jinyang Gu, Qiang Xia. Characterization of hepatitis B virus DNA integration patterns in intrahepatic cholangiocarcinoma. Hepatology Research 2021; 51(1): 102 doi: 10.1111/hepr.13580
|
| 15 |
Tae Y. Lee, Sang S. Lee, Seok W. Jung, Seong H. Jeon, Sung-Cheol Yun, Hyoung-Chul Oh, Seunghyun Kwon, Sung K. Lee, Dong W. Seo, Myung-Hwan Kim, Dong J. Suh. Hepatitis B Virus Infection and Intrahepatic Cholangiocarcinoma in Korea: A Case-Control Study. The American Journal of Gastroenterology 2008; 103(7): 1716 doi: 10.1111/j.1572-0241.2008.01796.x
|
| 16 |
Hui Wang, Xin‐Zu Chen, Xiao‐Long Chen, Wei‐Han Zhang, Kai Liu, You‐Juan Wang, Huai‐Rong Tang, Jian‐Kun Hu. Associations between hepatitis B virus exposure and the risk of extrahepatic digestive system cancers: A hospital‐based, case–control study (SIGES). Cancer Medicine 2021; 10(11): 3741 doi: 10.1002/cam4.3901
|
| 17 |
ANN W. HSING, ASIF RASHID, SUSAN S. DEVESA, JOSEPH F. FRAUMENI. Cancer Epidemiology and Prevention. 2006; : 787 doi: 10.1093/acprof:oso/9780195149616.003.0040
|
| 18 |
Katsuhiko Ito, Takayuki Ishii, Satoru Otawa, Yoshiaki Shimizu, Eisuke Kondo, Kei Nishiya, Kiyoshi Ogawa, Hirohisa Kishi, Kouji Azuhata, Masaru Miyazaki. A Case of Double Primary Liver Cancer (Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma) without Hepatitis C Virus and Hepatitis B Virus Infection. The Japanese Journal of Gastroenterological Surgery 2012; 45(10): 1026 doi: 10.5833/jjgs.45.1026
|
| 19 |
Kazuya Matsumoto, Takumi Onoyama, Soichiro Kawata, Yohei Takeda, Kenichi Harada, Yuichiro Ikebuchi, Masaru Ueki, Norimasa Miura, Kazuo Yashima, Masahiko Koda, Teruhisa Sakamoto, Masanori Endo, Yasushi Horie, Yoshikazu Murawaki. Hepatitis B and C Virus Infection is a Risk Factor for the Development of Cholangiocarcinoma. Internal Medicine 2014; 53(7): 651 doi: 10.2169/internalmedicine.53.1410
|
| 20 |
Nikolaos K. Gatselis, Konstantinos Tepetes, Argirios Loukopoulos, Katerina Vasiou, Athanasios Zafiriou, Chrisoula Gioti, Georgios N. Dalekos. Hepatitis B Virus and Intrahepatic Cholangiocarcinoma. Cancer Investigation 2007; 25(1): 55 doi: 10.1080/07357900601130722
|
| 21 |
Ann W. Hsing, Mingdong Zhang, Asif Rashid, Katherine A. McGlynn, Bing‐Shen Wang, Shelley Niwa, Betty A. Ortiz‐Conde, James J. Goedert, Joseph F. Fraumeni, Thomas R. O'Brien, Yu‐Tang Gao. Hepatitis B and C virus infection and the risk of biliary tract cancer: A population‐based study in China. International Journal of Cancer 2008; 122(8): 1849 doi: 10.1002/ijc.23251
|
| 22 |
Ann W. Hsing, Yu‐Tang Gao, Katherine A. McGlynn, Shelley Niwa, Mingdong Zhang, Tian‐Quan Han, Bing‐Sheng Wang, Jinbo Chen, Lori C. Sakoda, Ming‐Chang Shen, Bai‐He Zhang, Jie Deng, Asif Rashid. Biliary tract cancer and stones in relation to chronic liver conditions: A population‐based study in Shanghai, China. International Journal of Cancer 2007; 120(9): 1981 doi: 10.1002/ijc.22375
|
| 23 |
Min Li, Jinzheng Li, Peizhi Li, Hongyang Li, Tianyi Su, Rongtao Zhu, Jianping Gong. Hepatitis B virus infection increases the risk of cholangiocarcinoma: A meta‐analysis and systematic review. Journal of Gastroenterology and Hepatology 2012; 27(10): 1561 doi: 10.1111/j.1440-1746.2012.07207.x
|
| 24 |
Yanming Zhou, Yanfang Zhao, Bin Li, Jiyi Huang, Lupeng Wu, Donghui Xu, Jiamei Yang, Jia He. Hepatitis viruses infection and risk of intrahepatic cholangiocarcinoma: evidence from a meta-analysis. BMC Cancer 2012; 12(1) doi: 10.1186/1471-2407-12-289
|
| 25 |
Xiao-Zhong Wang, Xiao-Chun Chen, Yun-Xin Chen, Li-Juan Zhang, Dan Li, Feng-Lin Chen, Zhi-Xin Chen, Hong-Ying Chen, Qi-Ming Tao. Overexpression of HBxAg in hepatocellular carcinoma and its relationship with Fas/FasL system. World Journal of Gastroenterology 2003; 9(12): 2671-2675 doi: 10.3748/wjg.v9.i12.2671
|
| 26 |
S. Ralphs, S. A. Khan. The role of the hepatitis viruses in cholangiocarcinoma. Journal of Viral Hepatitis 2013; 20(5): 297 doi: 10.1111/jvh.12093
|
| 27 |
Zhenliang QU, Naiqiang CUI, Mingfang QIN, Xianzhong WU. Epidemiological survey of biomarkers of hepatitis virus in patients with extrahepatic cholangiocarcinomas. Asia-Pacific Journal of Clinical Oncology 2012; 8(1): 83 doi: 10.1111/j.1743-7563.2011.01466.x
|
| 28 |
Qing-He Nie, Yong-Qian Cheng, Yu-Mei Xie, Yong-Xing Zhou, Xian-Guang Bai, Yi-Zhan Cao. Methodologic research on TIMP-1, TIMP-2 detection as a new diagnostic index for hepatic fibrosis and its significance. World Journal of Gastroenterology 2002; 8(2): 282-287 doi: 10.3748/wjg.v8.i2.282
|
| 29 |
Shinichi Aishima, Yousuke Kuroda, Yunosuke Nishihara, Tomohiro Iguchi, Kenichi Taguchi, Akinobu Taketomi, Yoshihiko Maehara, Masazumi Tsuneyoshi. Proposal of Progression Model for Intrahepatic Cholangiocarcinoma: Clinicopathologic Differences Between Hilar Type and Peripheral Type. American Journal of Surgical Pathology 2007; 31(7): 1059 doi: 10.1097/PAS.0b013e31802b34b6
|
| 30 |
Michael Torbenson, Matthew M. Yeh, Susan C. Abraham. Bile Duct Dysplasia in the Setting of Chronic Hepatitis C and Alcohol Cirrhosis. American Journal of Surgical Pathology 2007; 31(9): 1410 doi: 10.1097/PAS.0b013e318053d122
|
| 31 |
R. Kannangai, E. Molmenti, L. Arrazola, A. Klein, M. Choti, D. L. Thomas, M. Torbenson. Occult hepatitis B viral DNA in liver carcinomas from a region with a low prevalence of chronic hepatitis B infection. Journal of Viral Hepatitis 2004; 11(4): 297 doi: 10.1111/j.1365-2893.2004.00502.x
|
| 32 |
Hiroaki Okuda, Keiko Shiratori, Masakazu Yamamoto, Ken Takasaki, Masayuki Nakano. Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for α‐fetoprotein‐L3 and those with combined hepatocellular and cholangiocarcinoma. Journal of Gastroenterology and Hepatology 2006; 21(5): 869 doi: 10.1111/j.1440-1746.2006.04257.x
|